ArticleThrombosis and haemostasis2022

Effectiveness and Safety of Apixaban versus Warfarin in Venous Thromboembolism Patients with Chronic Kidney Disease.

Alexander T Cohen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.